---
title: Sulforaphanes potential in neurodegenerative diseases
videoId: zz4YVJ4aRfg
---

From: [[foundmyfitness]] <br/> 

[[sulforaphane_and_its_health_benefits | Sulforaphane]] can cross the blood-brain barrier in mice <a class="yt-timestamp" data-t="00:26:47">[00:26:47]</a> and has potent effects on lowering inflammation <a class="yt-timestamp" data-t="00:26:52">[00:26:52]</a>. Since oxidative stress and inflammation are central to the etiology of many brain conditions <a class="yt-timestamp" data-t="00:26:54">[00:26:54]</a>, [[sulforaphane_and_its_health_benefits | sulforaphane]]'s role in activating the Nrf2 pathway, the body's strongest defense against oxidative stress <a class="yt-timestamp" data-t="00:27:01">[00:27:01]</a>, suggests its potential in [[lactates_potential_in_treating_neurodegenerative_diseases | neurodegenerative diseases]] <a class="yt-timestamp" data-t="00:27:12">[00:27:12]</a>.

## Impact on Specific [[lactates_potential_in_treating_neurodegenerative_diseases | Neurodegenerative Diseases]]

Brain inflammation and reactive oxygen species are hallmarks of [[lactates_potential_in_treating_neurodegenerative_diseases | neurodegenerative diseases]] such as Alzheimer's, Parkinson's, and Huntington's disease <a class="yt-timestamp" data-t="00:33:17">[00:33:17]</a>. This inflammation and high oxidative stress contribute to abnormal protein aggregates in the [[impact_of_sulforaphane_on_brain_health_and_behavior | brain]] <a class="yt-timestamp" data-t="00:33:24">[00:33:24]</a>.

Animal studies have shown:
*   **Alzheimer's Disease** Injections of [[sulforaphane_and_its_health_benefits | sulforaphane]] improved spatial working memory and short-term memory in mice injected with amyloid beta aggregates to induce an Alzheimer's-like disease <a class="yt-timestamp" data-t="00:33:32">[00:33:32]</a>.
*   **Parkinson's Disease** [[sulforaphane_and_its_health_benefits | Sulforaphane]] decreased tremors and normalized dopamine levels in mice given a chemical that induces Parkinson's disease <a class="yt-timestamp" data-t="00:33:46">[00:33:46]</a>.
*   **Huntington's Disease** It cleared aggregates from the brains of mice genetically engineered to have Huntington's disease <a class="yt-timestamp" data-t="00:33:52">[00:33:52]</a>.

As a potent inducer of the cellular antioxidant and anti-inflammatory network through Nrf2 activation <a class="yt-timestamp" data-t="00:33:59">[00:33:59]</a>, [[sulforaphane_and_its_health_benefits | sulforaphane]] has been shown to prevent neuron death and improve pathologies associated with [[lactates_potential_in_treating_neurodegenerative_diseases | neurodegenerative diseases]] in animal brains <a class="yt-timestamp" data-t="00:34:08">[00:34:08]</a>.

## Mechanisms of Action

[[sulforaphane_and_its_health_benefits | Sulforaphane]]'s effects in [[lactates_potential_in_treating_neurodegenerative_diseases | neurodegenerative diseases]] are likely mediated through several mechanisms:

*   **Nrf2 Activation** [[sulforaphane_and_its_health_benefits | Sulforaphane]] is the most potent naturally occurring inducer of the Nrf2 pathway <a class="yt-timestamp" data-t="00:09:47">[00:09:47]</a>, which controls hundreds of genes <a class="yt-timestamp" data-t="00:09:55">[00:09:55]</a>, many of which affect cellular aging <a class="yt-timestamp" data-t="00:23:38">[00:23:38]</a> and protect against disease <a class="yt-timestamp" data-t="00:23:41">[00:23:41]</a>. Nrf2 activity protects against inflammation and oxidative stress, which contribute to DNA damage and cellular aging <a class="yt-timestamp" data-t="00:23:51">[00:23:51]</a>. Nrf2 is also crucial for growing new neurons, regulated by growth factors that promote neuron growth and survival <a class="yt-timestamp" data-t="00:36:13">[00:36:13]</a>.
*   **Heat Shock Proteins** [[sulforaphane_and_its_health_benefits | Sulforaphane]] activates many heat shock proteins by increasing levels of heat shock factor one (HSF1) <a class="yt-timestamp" data-t="00:34:18">[00:34:18]</a>. The induction of heat shock proteins may be an additional mechanism against protein aggregation <a class="yt-timestamp" data-t="00:34:30">[00:34:30]</a>, which confers protection against Alzheimer's, Parkinson's, and Huntington's disease <a class="yt-timestamp" data-t="00:34:36">[00:34:36]</a>.

## Potential in Traumatic Brain Injury (TBI)

[[sulforaphane_and_its_health_benefits | Sulforaphane]] also has relevance for traumatic [[impact_of_sulforaphane_on_brain_health_and_behavior | brain]] injury (TBI), where chronic inflammation plays a major role in long-term outcomes <a class="yt-timestamp" data-t="00:35:00">[00:35:00]</a>. Several animal studies indicate that [[sulforaphane_and_its_health_benefits | sulforaphane]] can protect against TBI <a class="yt-timestamp" data-t="00:35:04">[00:35:04]</a>:
*   When administered via injection after TBI, [[sulforaphane_and_its_health_benefits | sulforaphane]] attenuated blood-brain barrier permeability, improving control over what enters the [[impact_of_sulforaphane_on_brain_health_and_behavior | brain]] <a class="yt-timestamp" data-t="00:35:14">[00:35:14]</a>.
*   It also reduced cerebral edema, regardless of how soon after injury it was given <a class="yt-timestamp" data-t="00:35:26">[00:35:26]</a>.
*   Enhanced learning and working memory were improved if [[sulforaphane_and_its_health_benefits | sulforaphane]] was administered within one hour post-injury <a class="yt-timestamp" data-t="00:35:32">[00:35:32]</a>.
*   Administration 15 minutes after the onset of ischemia (lack of oxygen in the [[impact_of_sulforaphane_on_brain_health_and_behavior | brain]]) caused a reduction in infarct volume (dead tissue) three days later <a class="yt-timestamp" data-t="00:35:41">[00:35:41]</a>.
*   [[sulforaphane_and_its_health_benefits | Sulforaphane]] increases neuro outgrowth in cultured neurons through Nrf2 activation <a class="yt-timestamp" data-t="00:35:57">[00:35:57]</a>. Neuro outgrowth is a vital mechanism for damaged neurons and synapses to repair themselves after TBI <a class="yt-timestamp" data-t="00:36:04">[00:36:04]</a>.
*   Rats with diabetes, which have reduced levels of neurotrophic factors like Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), saw these levels experimentally reversed by [[sulforaphane_and_its_health_benefits | sulforaphane]] administration <a class="yt-timestamp" data-t="00:36:41">[00:36:41]</a>. High inflammation and oxidative stress, countered by Nrf2, negatively affect neurotrophic factor production <a class="yt-timestamp" data-t="00:36:50">[00:36:50]</a>.
*   Rats with Nrf2 deleted had a 30% reduction in BDNF in the hippocampus, a 30% reduction in new synapse growth, and a 38% reduction in neuroplasticity in the hippocampus <a class="yt-timestamp" data-t="00:37:02">[00:37:02]</a>.

While the overall relevance of these animal studies to human [[lactates_potential_in_treating_neurodegenerative_diseases | neurodegenerative diseases]] is still being investigated, there is optimism for future research <a class="yt-timestamp" data-t="00:37:56">[00:37:56]</a>.